Atazanavir intracellular concentrations remain stable during pregnancy in HIV-infected patients
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Antimicrobial Chemotherapy"
DOI: 10.1093/jac/dkx274
Abstract: Background Atazanavir (300 mg) boosted by ritonavir (100 mg) is the preferred third drug in pregnancy. However, there is still discordance on atazanavir dose increase during the third trimester. Objectives To evaluate plasma and intracellular atazanavir and… read more here.
Keywords: pregnancy; intracellular concentrations; ritonavir; hiv infected ... See more keywords